Cash flows from operating activities: | |
Net loss | -12.12M |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Change in warrant value and gain from warrant exercise, net | |
Accrued incentive plan with related parties | |
Non-cash license revenue | 0 |
Depreciation and amortization | 523K |
Debt conversion costs | |
Loss on sale and disposal of property and equipment | 3K |
Stock-based compensation expense | 861K |
Changes in operating assets and liabilities: | |
Accounts receivable | -44K |
Prepaid expenses and other assets | 354K |
Accounts payable, accrued liabilities and other liabilities | -769K |
Deferred revenue | 0 |
Reorganization Items | |
Net cash used in operating activities | |
Cash flows from investing activities: | |
Purchase of property and equipment | -1.24M |
Proceeds from sale of property and equipment | |
Net cash used in investing activities | |
Cash flows from financing activities: | |
Principal repayment of debtor-in-possession loan financing with related party | |
Principal repayment of 4.50% convertible senior notes | |
Proceeds from sale of common stock, net of issuance costs | |
Proceeds from issuance of common stock from exercise of stock options | 5K |
Issuance costs related to stock warrant exercises | |
Issuance costs related to conversion of convertible senior notes | |
Net cash provided by financing activities | |
Effect of exchange rate changes on cash and cash equivalents | |
Net increase in cash and cash equivalents | -10.56M |
Cash and cash equivalents, beginning of period | 18.64M |
Cash and cash equivalents, end of period | 8.08M |
Supplemental disclosure of cash flow information: | |
Interest | 24K |
Noncash investing and financing activities: | |
Principal reduction from conversion of senior convertible notes | |
Principal reduction from forgiveness of Quest Diagnostics secured line of credit | |
Issuance of common stock from warrant exercise | |
Issuance of common stock from conversion of principal and interest for senior convertible notes | |
Unrealized loss (gain) on investments |